CITATIONS


JOP. J Pancreas (Online) 2002; 3(6):162-168.

Mechanisms Involved in the Onset of Post-ERCP Pancreatitis

Pezzilli R, Romboli E, Campana D, Corinaldesi R

Department of Internal Medicine and Gastroenterology, Sant’Orsola-M.Malpighi Hospital, University of Bologna. Bologna, Italy


Cited by:

12

Rochester JS. Risks of Endoscopic Retrograde Cholangiopancreatography and Sphincterotomy. Tech Gastrointest Endosc 2008; 10:14-21. [More details]

11

Rochester JS, Jaffe DL. Minimizing complications in endoscopic retrograde cholangiopancreatography and sphincterotomy. Gastrointest Endosc Clin N Am 2007; 17:105-27. [More details]

10

La Greca G, Barbagallo F, Di Blasi M, Di Stefano M, Castello G, Gagliardo S, et al. Rendezvous technique versus endoscopic retrograde cholangiopancreatography to treat bile duct stones reduces endoscopic time and pancreatic damage. J Laparoendosc Adv Surg Tech A 2007; 17(2):167-71. [More details]

9

Lieb JG 2nd, Draganov PV. Early successes and late failures in the prevention of post endoscopic retrograde cholangiopancreatography. World J Gastroenterol 2007; 13(26):3567-74. [More details]

8

Tsujino T, Kawabe T, Omata M. Antiproteases in Preventing Post-ERCP Acute Pancreatitis. JOP. J Pancreas (Online) 2007; 8(4 Suppl):509-517. [More details]

7

Li ZS, Pan X, Zhang WJ, Gong B, Zhi FC, Guo XG, et al. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial. Am J Gastroenterol 2007; 102(1):46-51. [More details]

6

La Greca G, Di Blasi M, Barbagallo F, Di Stefano M, Latteri S, Russello D. Acute biliary pancreatitis and cholecystolithiasis in a child: one time treatment with laparoendoscopic "rendez-vous" procedure. World J Gastroenterol 2006; 12(11):1782-5. [More details]

5

Hookey LC, RioTinto R, Delhaye M, Baize M, Le Moine O, Deviere J. Risk factors for pancreatitis after pancreatic sphincterotomy: a review of 572 cases. Endoscopy 2006; 38(7):670-6. [More details]

4

Hellmig S, Folsch UR. Pharmacological prevention of post-ERCP pancreatitis--an everlasting dream?. Dig Liver Dis 2006; 38(8):596-8. [More details]

3

Mishkin D, Carpenter S, Croffie J, Chuttani R, DiSario J, Hussain N, et al. ASGE Technology Status Evaluation Report: radiographic contrast media used in ERCP. Gastrointest Endosc 2005; 62(4):480-4. [More details]

2

Gottumukkala SR. Prevention of post-ERCP pancreatitis: are there any pearls for sale?. Gastroenterology 2004; 127(1):348-50. [More details]

1

Demols A, Deviere J. New Frontiers in the Pharmacological Prevention of Post-ERCP Pancreatitis: The Cytokines. JOP. J Pancreas (Online) 2003; 4(1):49-57. [More details]